We showed that MNX1, MNX1-AS1, and MNX1-AS2 expressions are dysregulated in most cancers analysed, with particularly high fold changes observed in uterine, prostate, oesophageal, colorectal, and lung cancers. This evidence concerns the gene MNX1 and lung carcinoma.